These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 3093116

  • 1. Synergism of thrombolytic agents in vivo.
    Collen D, Stassen JM, Stump DC, Verstraete M.
    Circulation; 1986 Oct; 74(4):838-42. PubMed ID: 3093116
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effect on thrombolysis of sequential infusion of tissue-type plasminogen activator (t-PA) single-chain urokinase-type plasminogen activator (scu-PA) and urokinase in the rabbit jugular vein thrombosis model.
    Collen D, Stassen JM, De Cock F.
    Thromb Haemost; 1987 Oct 28; 58(3):943-6. PubMed ID: 3124288
    [Abstract] [Full Text] [Related]

  • 3. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 4. Comparative thrombolytic properties of bolus injections and continuous infusions of a chimeric (t-PA/u-PA) plasminogen activator in a hamster pulmonary embolism model.
    Lu HR, Lijnen HR, Stassen JM, Collen D.
    Blood; 1991 Jul 01; 78(1):125-31. PubMed ID: 1906351
    [Abstract] [Full Text] [Related]

  • 5. Comparative thrombolytic properties of single-chain forms of urokinase-type plasminogen activator.
    Stump DC, Stassen JM, Demarsin E, Collen D.
    Blood; 1987 Feb 01; 69(2):592-6. PubMed ID: 3099862
    [Abstract] [Full Text] [Related]

  • 6. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D, Lu HR, Lijnen HR, Nelles L, Stassen JM.
    Circulation; 1991 Sep 01; 84(3):1216-34. PubMed ID: 1909220
    [Abstract] [Full Text] [Related]

  • 7. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D.
    J Am Coll Cardiol; 1992 May 01; 19(6):1350-9. PubMed ID: 1342779
    [Abstract] [Full Text] [Related]

  • 8. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M, Vandamme AM, Holvoet P, De Cock F, Lemmens G, Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1992 Aug 03; 68(2):170-9. PubMed ID: 1412163
    [Abstract] [Full Text] [Related]

  • 9. Molecular mechanism of action of newer thrombolytic agents.
    Collen D.
    J Am Coll Cardiol; 1987 Nov 03; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
    [Abstract] [Full Text] [Related]

  • 10. Thrombolytic therapy.
    Collen D, Stump DC, Gold HK.
    Annu Rev Med; 1988 Nov 03; 39():405-23. PubMed ID: 3130773
    [Abstract] [Full Text] [Related]

  • 11. Synergy of in vitro thrombolytic action of combinations of recombinant staphylokinase and single-chain urokinase-type plasminogen activator.
    Aisina RB, Moukhametova LI, Varfolomeyev SD.
    Biochemistry (Mosc); 2003 Nov 03; 68(11):1252-60. PubMed ID: 14640969
    [Abstract] [Full Text] [Related]

  • 12. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D.
    Prog Hemost Thromb; 1986 Nov 03; 8():1-18. PubMed ID: 3104986
    [No Abstract] [Full Text] [Related]

  • 13. The nature of synergy between tissue-type and single chain urokinase-type plasminogen activators.
    Fry ET, Mack DL, Sobel BE.
    Thromb Haemost; 1989 Nov 24; 62(3):909-16. PubMed ID: 2512679
    [Abstract] [Full Text] [Related]

  • 14. Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis.
    Badylak SF, Voytik S, Klabunde RE, Henkin J, Leski M.
    Thromb Res; 1988 Nov 15; 52(4):295-312. PubMed ID: 3144052
    [Abstract] [Full Text] [Related]

  • 15. Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.
    Collen D, Stassen JM, Verstraete M.
    J Clin Invest; 1983 Feb 15; 71(2):368-76. PubMed ID: 6681615
    [Abstract] [Full Text] [Related]

  • 16. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
    Abercrombie DM, Buchinski B, Salvato KA, Vovis GF, Stump DC, Broeze RJ.
    Thromb Haemost; 1990 Nov 30; 64(3):426-32. PubMed ID: 2128973
    [Abstract] [Full Text] [Related]

  • 17. [New thrombolytic agents in myocardial infarction].
    Charbonnier B, Lang M, Brochier M.
    Arch Mal Coeur Vaiss; 1987 Nov 30; 80(12):1785-91. PubMed ID: 3128222
    [Abstract] [Full Text] [Related]

  • 18. Additive fibrinolysis by recombinant tissue-type plasminogen activator (r-t-PA) and recombinant single-chain urokinase type plasminogen activator (r-scu-PA) in rabbit pulmonary thrombosis.
    Schneider J, Friderichs E, Günzler WA, Flohé L.
    Thromb Res; 1989 Oct 01; 56(1):59-65. PubMed ID: 2512686
    [Abstract] [Full Text] [Related]

  • 19. Comparison of intravenous bolus injection or continuous infusion of recombinant single chain urokinase-type plasminogen activator (saruplase) for thrombolysis. A canine model of combined coronary arterial and femoral venous thrombosis.
    Rapold HJ, Wu ZM, Stassen T, Van de Werf F, Collen D.
    Blood; 1990 Oct 15; 76(8):1558-63. PubMed ID: 2119830
    [Abstract] [Full Text] [Related]

  • 20. Comparison of thrombolytic, fibrinolytic, and fibrinogenolytic properties of tissue plasminogen activator, streptokinase, single-chain urokinase, high molecular weight and low molecular weight urokinase in human plasma in vitro.
    Samama M, Nguyen G, Desnoyers P, Lourenco DM, Fretault J, Horellou MH, Conard J, Szwarcer E, Verdy E, Vahanian A.
    Fundam Clin Pharmacol; 1988 Oct 15; 2(6):509-23. PubMed ID: 3149257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.